News
Faron Pharmaceuticals sai Yhdysvaltain FDA:lta myönteisen palautteen bexmarilimabin kliinisen kehityksen etenemisestä.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback